A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug ...

Alzheimer’s Association urging ‘action now’ for awareness month June is Alzheimer’s and Brain Awareness Month, and the Alzheimer’s Association is urging patients, caregivers, and supporters to “take ...

Alzheimer's disease destroys brain cells, affecting a person's behavior, memory, speech, thinking. Here's suggestions on living with Alzheimer's Disease.

Learn more about Alzheimer's disease, the most common cause of dementia and an irreversible, progressive neurological disorder.

In early-stage Alzheimer's, changes in abilities or behavior may be minor and only noticeable to family and close friends. Some symptoms typify this stage.

Diagnosis of Alzheimer's disease involves assessing patients' medical history, symptoms, lab tests, and using brain imaging to rule out other conditions.

The small snacks available in the U.S. and U.K. encourage people with Alzheimer's and dementia to increase their water intake.

Moderate stage Alzheimer's is the second and longest stage of this brain disease, likely marked by increased forgetfulness, confusion, and trouble speaking.

AlzoSure Predict, a biomarker blood test, helps to predict the likelihood of adults with mild cognitive issues progressing to Alzheimer's.

Consider the following before gently correcting your loved one: The present stage of dementia and your loved one’s ability to process information. Is the behavior connected to dementia, or was it ...

Nearly half the Alzheimer's disease patients treated with TrueBinding's investigational therapy TB006 showed cognitive improvement signs.

In a significant decision, the FDA approved Adulhelm (aducanumab) as a first targeted Alzheimer's treatment, and first new therapy since 2003.